Barrington Research Reiterates Outperform on Dentsply Sirona, Maintains $41 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has reiterated an Outperform rating on Dentsply Sirona (NASDAQ:XRAY) and maintained a $41 price target.

March 01, 2024 | 3:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research maintains an Outperform rating and a $41 price target on Dentsply Sirona.
The reiteration of an Outperform rating and maintenance of a $41 price target by a reputable analyst firm like Barrington Research is likely to instill confidence among investors and could positively influence Dentsply Sirona's stock price in the short term. Analyst ratings often impact investor sentiment and can lead to price movements.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100